US Stock MarketDetailed Quotes

RAPP Rapport Therapeutics

Watchlist
  • 20.460
  • +0.190+0.94%
Close Dec 6 16:00 ET
  • 20.460
  • 0.0000.00%
Post 20:01 ET
748.35MMarket Cap-10417P/E (TTM)

Rapport Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
126.27%21.64M
213.73%20.8M
229.30%17.09M
36.18M
14.79M
9.56M
6.63M
5.19M
Selling and administrative expenses
207.31%6.1M
167.73%5.11M
255.26%4.59M
--8.18M
--3M
--1.98M
--1.91M
--1.29M
-General and administrative expense
207.31%6.1M
167.73%5.11M
255.26%4.59M
--8.18M
--3M
--1.98M
--1.91M
--1.29M
Research and development costs
105.05%15.54M
232.32%15.69M
220.70%12.5M
--28M
--11.8M
--7.58M
--4.72M
--3.9M
Operating profit
-126.27%-21.64M
-213.73%-20.8M
-229.30%-17.09M
-36.18M
-14.79M
-9.56M
-6.63M
-5.19M
Net non-operating interest income expense
379.32%4.1M
1,112.22%2.68M
2,320.00%1.82M
2.53M
1.38M
856K
221K
75K
Non-operating interest income
379.32%4.1M
1,112.22%2.68M
2,320.00%1.82M
--2.53M
--1.38M
--856K
--221K
--75K
Non-operating interest expense
----
----
----
--0
----
----
----
----
Other net income (expense)
-617.48%-7.39M
-1.12M
-94K
-1.03M
Other non- operating income (expenses)
----
----
-617.48%-7.39M
---1.12M
---94K
----
----
---1.03M
Income before tax
-101.39%-17.54M
-182.74%-18.12M
-268.84%-22.67M
-34.78M
-13.51M
-8.71M
-6.41M
-6.15M
Income tax
0
0
0
10K
6K
1K
2K
1K
Net income
-101.37%-17.54M
-182.65%-18.12M
-268.78%-22.67M
-34.79M
-13.52M
-8.71M
-6.41M
-6.15M
Net income continuous Operations
-101.37%-17.54M
-182.65%-18.12M
-268.78%-22.67M
---34.79M
---13.52M
---8.71M
---6.41M
---6.15M
Minority interest income
Net income attributable to the parent company
-101.37%-17.54M
-182.65%-18.12M
-268.78%-22.67M
-34.79M
-13.52M
-8.71M
-6.41M
-6.15M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-101.37%-17.54M
-182.65%-18.12M
-268.78%-22.67M
-34.79M
-13.52M
-8.71M
-6.41M
-6.15M
Basic earnings per share
-38.90%-0.5
-541.54%-1.7
-269.97%-0.94
-1.47
-0.3821
-0.36
-0.265
-0.2541
Diluted earnings per share
-38.90%-0.5
-541.54%-1.7
-269.97%-0.94
-1.47
-0.3821
-0.36
-0.265
-0.2541
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 00000000
Operating revenue --0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 126.27%21.64M213.73%20.8M229.30%17.09M36.18M14.79M9.56M6.63M5.19M
Selling and administrative expenses 207.31%6.1M167.73%5.11M255.26%4.59M--8.18M--3M--1.98M--1.91M--1.29M
-General and administrative expense 207.31%6.1M167.73%5.11M255.26%4.59M--8.18M--3M--1.98M--1.91M--1.29M
Research and development costs 105.05%15.54M232.32%15.69M220.70%12.5M--28M--11.8M--7.58M--4.72M--3.9M
Operating profit -126.27%-21.64M-213.73%-20.8M-229.30%-17.09M-36.18M-14.79M-9.56M-6.63M-5.19M
Net non-operating interest income expense 379.32%4.1M1,112.22%2.68M2,320.00%1.82M2.53M1.38M856K221K75K
Non-operating interest income 379.32%4.1M1,112.22%2.68M2,320.00%1.82M--2.53M--1.38M--856K--221K--75K
Non-operating interest expense --------------0----------------
Other net income (expense) -617.48%-7.39M-1.12M-94K-1.03M
Other non- operating income (expenses) ---------617.48%-7.39M---1.12M---94K-----------1.03M
Income before tax -101.39%-17.54M-182.74%-18.12M-268.84%-22.67M-34.78M-13.51M-8.71M-6.41M-6.15M
Income tax 00010K6K1K2K1K
Net income -101.37%-17.54M-182.65%-18.12M-268.78%-22.67M-34.79M-13.52M-8.71M-6.41M-6.15M
Net income continuous Operations -101.37%-17.54M-182.65%-18.12M-268.78%-22.67M---34.79M---13.52M---8.71M---6.41M---6.15M
Minority interest income
Net income attributable to the parent company -101.37%-17.54M-182.65%-18.12M-268.78%-22.67M-34.79M-13.52M-8.71M-6.41M-6.15M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -101.37%-17.54M-182.65%-18.12M-268.78%-22.67M-34.79M-13.52M-8.71M-6.41M-6.15M
Basic earnings per share -38.90%-0.5-541.54%-1.7-269.97%-0.94-1.47-0.3821-0.36-0.265-0.2541
Diluted earnings per share -38.90%-0.5-541.54%-1.7-269.97%-0.94-1.47-0.3821-0.36-0.265-0.2541
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------
Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data